Michel Vounatsos
2020
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $264,358 |
|---|---|
| Non-Equity Incentive Plan | $2,565,000 |
| Salary | $1,488,462 |
| Stock Awards | $13,887,064 |
| Other | $454,945 |
| Total | $18,659,829 |
Vounatsos received $13.9M in stock awards, accounting for 74% of the total pay in 2020.
Vounatsos also received $264.4K of change in pension value and nonqualified deferred compensation earnings, $2.6M in non-equity incentive plan, $1.5M in salary and $454.9K in other compensation.
Rankings
In 2020, Michel Vounatsos' compensation ranked 258th out of 13,090 executives tracked by ExecPay. In other words, Vounatsos earned more than 98.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 258 out of 13,090 | 98th |
Division Manufacturing | 77 out of 5,621 | 99th |
Major group Chemicals And Allied Products | 21 out of 2,254 | 99th |
Industry group Drugs | 20 out of 1,954 | 99th |
Industry Biological Products, Except Diagnostic Substances | 9 out of 411 | 98th |
Pay ratio
| Michel Vounatsos' Pay | $18,659,829 |
|---|---|
| Median Employee's Pay | $155,378 |
| Pay Ratio | 120to 1 |
In 2020, the annual total compensation of Michel Vounatsos was $18,659,829.
The annual total compensation of the median employee at Biogen was $155,378.
The ratio of Michel Vounatsos' pay to the pay of median employee was therefore 120 to one.
Vounatsos' colleagues
We found five more compensation records of executives who worked with Michel Vounatsos at Biogen in 2020.
2020
Jeffrey Capello
Biogen
Chief Financial Officer
2020
Michael McDonnell
Biogen
Chief Financial Officer
2020
Alfred Sandrock
Biogen
Executive Vice President, Research & Development
2020
Susan Alexander
Biogen
Chief Legal Officer
2020
Chirfi Guindo
Biogen